The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Open accessAbstract
Applications of adenine base editors (ABEs) have been constrained by the limited compatibility of the deoxyadenosine deaminase component with Cas homologs other than SpCas9. We evolved the deaminase component of ABE7.10 using phage-assisted non-continuous and continuous evolution (PANCE and PACE), which resulted in ABE8e. ABE8e contains eight additional mutations that increase activity (k app) 590-fold compared with that of ABE7.10. ABE8e offers substantially improved editing efficiencies when paired with a variety of Cas9 or Cas12 homologs. ABE8e is more processive than ABE7.10, which could benefit screening, disruption of regulatory regions and multiplex base editing applications. A modest increase in Cas9-dependent and -independent DNA off-target editing, and in transcriptome-wide RNA off-target editing can be ameliorated by the introduction of an additional mutation in the TadA-8e domain. Finally, we show that ABE8e can efficiently install natural mutations that upregulate fetal hemoglobin expression in the BCL11A enhancer or in the the HBG promoter in human cells, targets that were poorly edited with ABE7.10. ABE8e augments the effectiveness and applicability of adenine base editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“ABE8e has an “editing window,” the nucleotides accessible for deamination, of positions 4–9 in the protospacer (11–16 bases upstream from the PAM).16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, accumulative studies have proved that sgRNA-independent off-target effects also exist, urging unbiased experimental detection and validation (Richter et al., 2020; O'Geen et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The sgRNA-independent DNA editing is likely deposited on loci where DNA unwinds into an R-loop so single-strand genomic DNA is exposed to deaminases”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ABE8e, a variant published in 2020, exhibits a 590-fold increase in activity due to numerous mutations in the TadA deaminase domain.16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Truncated gRNA: truncated by 2-3bp at 5’ end | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Extended gRNA: GGX20 | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Self-citationClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
Liu, Z., Lu, Z., Yang, G., Huang, S., Li, G., Feng, S., Liu, Y., Li, J., Yu, W., Zhang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04768-7 · Cited by 2,103
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Self-citationCRISPResso2 provides accurate and rapid genome editing sequence analysis
Clement, K., Rees, H. A., Canver, M. C., Gehrke, J. M., Farouni, R., Hsu, J. Y., Cole, M. A., Liu, D. R., Joung, J. K., Bauer, D. E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0032-3 · Cited by 1,656
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,000
Jalil, S., Keskinen, T., Juutila, J., Sartori-Maldonado, R., Euro, L., Suomalainen, A., Lapatto, R., Kuuluvainen, E., Hietakangas, V., Otonkoski, T., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.03.004 · Cited by 18
Engineering miniature CRISPR-Cas Un1Cas12f1 for efficient base editing
Hu, Y., Han, L., Mo, Q., Du, Z., Jiang, W. Q., Wu, X., Zheng, J., Xiao, X., Sun, Y., & Ma, H. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102201 · Cited by 17
Accelerating Genetic Sensor Development, Scale-up, and Deployment Using Synthetic Biology
Joshi, S. H.-N., Jenkins, C., Ulaeto, D., & Gorochowski, T. E. (2024) · BioDesign Research · doi:10.34133/bdr.0037 · Cited by 21
Mitochondrial base editing: from principle, optimization to application
Tang, J., & Du, K. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01351-8 · Cited by 18
Recent advances in CRISPR technologies for genome editing
Song, M., & Koo, T. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01336-4 · Cited by 18
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease
Ramadier, S., Chalumeau, A., Félix, T., Othman, N., Aknoun, S., Casini, A., Maule, G., Masson, C., Cian, A. D., Frati, G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.019 · Cited by 17
Perfecting Targeting in CRISPR
Zhang, H., Li, T., Sun, Y., & Yang, H. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-030438 · Cited by 18
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations
Choi, E., Hwang, H.-Y., Kwon, E., Kim, D., & Koo, T. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.09.005 · Cited by 18
New Directions in Pulmonary Gene Therapy
Vu, A., & McCray, P. B. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.166 · Cited by 19
Precise base editing without unintended indels in human cells and mouse primary myoblasts
Yoon, D. E., Kim, N., Park, S.-J., Jeong, T. Y., Eun, B., Cho, Y., Lim, S., Lee, H., Seong, J. K., & Kim, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01128-4 · Cited by 15
Nicosia, L., Pranke, I. M., Latorre, R. V., Murray, J. B., Lonetti, L., Cavusoglu-Doran, K., Dréano, E., Costello, J. P., Carroll, M. A., Melotti, P., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111979 · Cited by 17
Walsh, Z. H., Frangieh, C. J., Kothapalli, N., Levy, J. A., Heck, C., Melms, J. C., Gejman, R. S., Shah, P., Pollard, J. M., Naik, A., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.037 · Cited by 16
Advances and Applications of Plant Base Editing Technologies
Peng, H. F., Li, J., Sun, K., Tang, H., Huang, W., Li, X., Wang, S., Ding, K., Han, Z., Li, Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199452 · Cited by 20
Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery
Gil, J.-S., Lee, S., & Koo, T. (2025) · Gene Therapy · doi:10.1038/s41434-025-00573-2 · Cited by 19
The application of new breeding technology based on gene editing in pig industry — A review
Tu, C., Chuang, C.-K., & Yang, T. (2022) · Animal Bioscience · doi:10.5713/ab.21.0390 · Cited by 16
Li, G., Cheng, Y., Li, Y., Ma, H., Pu, Z., Li, S., Zhao, Y., Huang, X., & Yao, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.12.001 · Cited by 16
Genome editing for plant synthetic metabolic engineering and developmental regulation
Tan, J., Shen, M., Chai, N., Liu, Q., Liu, Y., & Zhu, Q. (2023) · Journal of Plant Physiology · doi:10.1016/j.jplph.2023.154141 · Cited by 16
Zhou, C., Okuno, M., Nakazato, I., Tsutsumi, N., & Arimura, S. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad678 · Cited by 16
Tools for editing the mammalian mitochondrial genome
Moraes, C. T. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae037 · Cited by 16
Banda, A., Impomeni, O., Singh, A., Baloch, A. R., Hu, W., & Jaijyan, D. K. (2024) · Vaccines · doi:10.3390/vaccines12060636 · Cited by 16
QBEmax is a sequence-permuted and internally protected base editor
Hu, J., Guo, M., Gao, Q., Jia, H., He, M., Wang, Z., Guo, L., Liu, G., Gao, Q., & Zhao, K. T. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02641-9 · Cited by 16
Self-citationRewriting CFTR to cure cystic fibrosis
Maule, G., Ensinck, M. M., Bulcaen, M., & Carlon, M. S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.018 · Cited by 17
Rehman, R. S., Zafar, S. A., Ali, M., Pasha, A. N., Naveed, M. S., Waseem, M., Ahmad, M., & Raza, A. (2022) · Asian Plant Research Journal · doi:10.9734/aprj/2022/v9i130197 · Cited by 16
Correction of the pathogenic mutation in TGM1 gene by adenine base editing in mutant embryos
Dang, L., Zhou, X., Zhong, X., Yu, W., Huang, S., Liu, H., Chen, Y., Zhang, W., Yuan, L., Li, L., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.007 · Cited by 16
Ukaji, T., Arai, D., Tsutsumi, H., Nakagawa, R., Matsumoto, F., Ikeda, K., Nureki, O., & Kamiya, K. (2025) · JCI Insight · doi:10.1172/jci.insight.185193 · Cited by 15
Selict-seq profiles genome-wide off-target effects in adenosine base editing
Yuan, K., Xin, X., Han, S., Han, J., Zhao, B., Wei, Q., & Zhou, X. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf281 · Cited by 18
A streamlined base editor engineering strategy to reduce bystander editing
Valdez, I., O’Connor, I., Patel, D., Gierer, K., Harrington, J., Ellis, E., Caponetti, S. A., Sebra, R., Valley, H. C., Coote, K. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63609-6 · Cited by 17
Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances
Mei, J., Ding, P., Gao, C., Zhou, J., Li, Z., Zhang, C., & Gao, J. (2025) · MedComm · doi:10.1002/mco2.70385 · Cited by 17
Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
Mariot, V., & Dumonceaux, J. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.937879 · Cited by 16
In vivo application of base and prime editing to treat inherited retinal diseases
Jo, D. H., Bae, S., Kim, S., Kim, J., & Kim, J. H. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101132 · Cited by 15
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Xia, Y., Sun, L., Liang, Z., Guo, Y., Li, J., Tang, D., Huo, Y., & Guo, S. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.143865 · Cited by 15
Programmed RNA editing with an evolved bacterial adenosine deaminase
Yan, H., & Tang, W. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01661-x · Cited by 15
CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come
Ren, C., Mohamed, M. S. M., Aini, N., Kuang, Y., & Liang, Z. (2024) · Horticulturae · doi:10.3390/horticulturae10090965 · Cited by 18
Engineering biotic stress tolerance via CRISPR-Cas mediated genome editing in crop plants
Hussain, A., Munir, M., Khalid, A., Ali, M., Amanullah, M., Ali, Q., & Manghwar, H. (2024) · Plant Stress · doi:10.1016/j.stress.2024.100650 · Cited by 15
Advances in base editing: A focus on base transversions
Wang, D., Zhang, Y., Zhang, J., & Zhao, J. (2024) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2024.108515 · Cited by 16
Enhancing the quality of staple food crops through CRISPR/Cas-mediated site-directed mutagenesis
Adeyinka, O. S., Tabassum, B., Landry, K. B., & Ogungbe, I. V. (2023) · Planta · doi:10.1007/s00425-023-04110-6 · Cited by 16
SpRY greatly expands the genome editing scope in rice with highly flexible PAM recognitionPreprint
Xu, Z., Kuang, Y., Ren, B., Yan, D., Yan, F., Spetz, C., Sun, W., Wang, G., Zhou, X., & Zhou, H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.23.310839 · Cited by 15
AI sheds new light on genome editing
Qin, Z. S., Deng, Z., Li, C., Wang, D., Ji, X., & Chen, Z. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.07.011 · Cited by 15
Application of CRISPR-Cas System to Mitigate Superbug Infections
Rabaan, A. A., Fares, M. A. A., Almaghaslah, M., Alpakistany, T. A., Kaabi, N. A., Alshamrani, S., Alshehri, A. A., Almazni, I. A., Saif, A., Hakami, A. R., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11102404 · Cited by 14
Sun, Y., Chen, Q., Cheng, Y., Wang, X., Deng, Z., Zhou, F., & Sun, Y. (2023) · Advanced Science · doi:10.1002/advs.202305311 · Cited by 14
Guri, I., Alrokh, Y., Kim, Y., Maeshima, R., Graham, C., Hart, S. L., McGrath, J. A., & Jackow, J. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad528 · Cited by 20
Gao, S., Guan, H., Bloomer, H., Wich, D., Song, D., Khirallah, J., Ye, Z., Zhao, Y., Chen, M., Xu, C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308415120 · Cited by 16
Dziubańska-Kusibab, P. J., Nevedomskaya, E., & Haendler, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020705 · Cited by 14
Advanced Genome Editing Technologies: Potentials and Prospects in Improvement of Sugar crops
Amaresh, G., Nunavath, A., Appunu, C., Viswanathan, C., KUMAR, R. R., Gujjar, R. S., & Manimekalai, R. (2024) · Sugar Tech · doi:10.1007/s12355-024-01447-4 · Cited by 14
Gene editing in common cardiovascular diseases
Lauerer, A.-M., Caravia, X. M., Maier, L. S., Chemello, F., & Lebek, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108720 · Cited by 15
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy
de Morais, C. C. P. D. L., Correia, E. M., Bonamino, M., & de Vasconcelos, Z. F. M. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.020 · Cited by 15
Yin, S., Gao, L., Sun, X., Zhang, M., Gao, H.-Y., Chen, X., Zhang, D., Ming, X., Yang, L., Hu, Y., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.032 · Cited by 14
Adenine base-editing-mediated exon skipping induces gene knockout in cultured pig cells
Zhu, X., Pan, J.-S., Lin, T., Yang, Y., Huang, Q., Yang, S.-P., Qu, Z.-X., Lin, Z.-S., Wen, J.-C., Yan, A., et al. (2022) · Biotechnology Letters · doi:10.1007/s10529-021-03214-x · Cited by 14
The Power of Gene Technologies: 1001 Ways to Create a Cell Model
Karagyaur, M. N., Primak, A. L., Efimenko, A. Y., Никитична, С. М., & Va, T. (2022) · Cells · doi:10.3390/cells11203235 · Cited by 14
Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
Gapinske, M., Winter, J., Swami, D., Gapinske, L., Woods, W. S., Shirguppe, S., Miskalis, A., Busza, A. M., Joulani, D., Kao, C. J., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.029 · Cited by 16
Boosting genome editing in plants with single transcript unit surrogate reporter systems
Tang, X., Ren, Q., Yan, X., Zhang, R., Liu, L., Han, Q., Zheng, X., Qi, Y., Song, H., & Zhang, Y. (2024) · Plant Communications · doi:10.1016/j.xplc.2024.100921 · Cited by 15
Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases
Zhang, C., Xu, J., Wu, Y., Xu, C., & Xu, P. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10715-5 · Cited by 16
Gene editing therapy for cardiovascular diseases
Wu, X., Yang, J., Zhang, J., & Song, Y. (2024) · MedComm · doi:10.1002/mco2.639 · Cited by 14
Current Knowledge of Base Editing and Prime Editing
Averina, O. A., Kuznetsova, S. A., Permyakov, O. A., & Владимирович, С. П. (2024) · Molecular Biology · doi:10.1134/s0026893324700195 · Cited by 14
Kulhánková, K., Cheng, A. X., Traore, S., Auger, M., Pelletier, M., Hervault, M., Wells, K. D., Green, J. A., Byrne, A. K., Nelson, B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae819 · Cited by 14
Self-citationTachida, Y., Manian, K. V., Butcher, R. M., Levy, J. M., Pendse, N. D., Hennessey, E., Liu, D. R., Pierce, E. A., Liu, Q., & Comander, J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.042 · Cited by 13
Self-citationMultiplex base editing to protect from CD33 directed drugs for immune and gene therapy
Borot, F., Humbert, O., Ehmsen, J. T., Fields, E., Kohli, S., Radtke, S., Swing, K., Pande, D., Enstrom, M., Laszlo, G. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59713-2 · Cited by 17
Self-citationIn vivo precision base editing to rescue mouse models of disease
Schindeler, A., Chu, J., Au-Yeung, C., Kao, H.-Y., Ginn, S. L., & O’Donohue, A. K. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102622 · Cited by 15
Expanding the Editing Window of Cytidine Base Editors With the Rad51 DNA-Binding Domain in Rice
Wei, C., Liu, H., Wang, W., Luo, P., Chen, Q., Li, R., Wang, C., Botella, J. R., & Zhang, H. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.865848 · Cited by 13
Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease
Caravia, X. M., Hayashi, B., Li, H. Z., Gan, P., Alzhanov, D., Tan, W. H., Chen, K., McAnally, J., Xu, L., Liu, N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2515267122 · Cited by 12
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
Li, R., Wang, Q., She, K., Lu, F., & Yang, Y. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00095-y · Cited by 13
Advancements of CRISPR-Mediated Base Editing in Crops and Potential Applications in Populus
Yang, X., Zhu, P., & Gui, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158314 · Cited by 13
Oliynyk, R. T., & Church, G. M. (2025) · Nature Protocols · doi:10.1038/s41596-024-01138-0 · Cited by 12
Characterization of diverse Cas9 orthologs for genome and epigenome editing
Butterfield, G. L., Rohm, D., Roberts, A., Nethery, M. A., Rizzo, A. J., Morone, D. J., Garnier, L., Iglesias, N., Barrangou, R., & Gersbach, C. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417674122 · Cited by 14
CABE-RY: A PAM-flexible dual-mutation base editor for reliable modeling of multi-nucleotide variants
Tao, W., Liu, Q., Huang, S., Wang, X., Qu, S., Guo, J., Ou, D., Li, G., Zhang, Y., Xu, X., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.016 · Cited by 12
Engineered PROTAC-CID Systems for Mammalian Inducible Gene Regulation
Ma, D., Yuan, Q., Peng, F., Paredes, V., Zeng, H., Osikpa, E. C., Yang, Q., Peddi, A., Patel, A., Liu, M. S., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09129 · Cited by 14
In vivo adenine base editing corrects newborn murine model of Hurler syndrome
Su, J., Jin, X., She, K., Liu, Y., Song, L., Zhao, Q., Xiao, J., Li, R., Deng, H., Lü, F., et al. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00120-8 · Cited by 13
Translational potential of base-editing tools for gene therapy of monogenic diseases
Reshetnikov, V. V., Chirinskaite, A. V., Sopova, J. V., Ivanov, R. A., & Леонова, Е. И. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.942440 · Cited by 13
Jo, D. H., Jang, H., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.07.425822 · Cited by 12
Current trends in gene therapy to treat inherited disorders of the brain
Matuszek, Ż., Brown, B. L., Yrigollen, C. M., Keiser, M. S., & Davidson, B. L. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.057 · Cited by 13
Gene Editing Applications as Future Cardiovascular Therapies
Tadokoro, T., Olson, E. N., & Liu, N. (2025) · Annual Review of Genetics · doi:10.1146/annurev-genet-011725-094039 · Cited by 11
Evaluation and prediction of guide RNA activities in genome-editing tools
Kim, H. K., & Kim, S. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00352-z · Cited by 12
Noncanonical target-strand cytosine base editing via engineered Un1Cas12f1 platform
Song, Z., Guo, J., Fan, Z., Huang, S., Li, G., Zhao, Z., Chen, B., Huang, S., Zheng, W., Wei, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64562-0 · Cited by 11
Yang, Y., Zhang, C., Song, Y., Li, Y., Li, P., Huang, M., Meng, F., & Zhang, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac742 · Cited by 11
Adair, B., Korecki, A. J., Djaksigulova, D., Wagner, P. K., Chiu, N. Y., Lam, S. L., Lengyell, T. C., Leavitt, B. R., & Simpson, E. M. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00729-6 · Cited by 11
Rajendiran, V., Devaraju, N., Haddad, M., Ravi, N. S., Panigrahi, L., Paul, J., Gopalakrishnan, C., Wyman, S. K., Ariudainambi, K., Mahalingam, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.023 · Cited by 12
Directed mutagenesis in plants through genome editing using guide RNA library
Dutta, S., Paul, D., Das, A., Kumar, S., Roy, A., Barua, A., & Chinnusamy, V. (2024) · The Nucleus · doi:10.1007/s13237-024-00481-7 · Cited by 11
Insights into the compact CRISPR–Cas9d system
Yang, J., Wang, T., Huang, Y., Long, Z., Li, X., Zhang, S., Zhang, L., Liu, Z., Zhang, Q., Sun, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57455-9 · Cited by 14
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases
Geiger, A., Kennedy, J. G., Staker, L. G., Wensel, T. G., Casson, R. J., & Thomas, P. Q. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101376 · Cited by 11
Charting the development and engineering of CRISPR base editors: lessons and inspirations
Zou, S., Sun, Y., & Tang, W. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.05.003 · Cited by 11
Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management
Kang, C. Y., Been, K. W., Kang, M. R., Choi, M. S., Kang, R. H., Hur, J. W., & Hur, J. K. (2025) · Neurospine · doi:10.14245/ns.2550462.231 · Cited by 15
Rong, L., Chen, D., Huang, X., & Sun, L. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.076 · Cited by 11
Skrekas, C., Limeta, A., Siewers, V., & David, F. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00690 · Cited by 11
CRISPR base editor-based targeted random mutagenesis (BE-TRM) toolbox for directed evolution
Shelake, R. M., Pramanik, D., & Kim, J. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0086 · Cited by 11
Gee, M. S., Kwon, E., Song, M.-H., Jeon, S. H., Kim, N., Lee, J. K., & Koo, T. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00415-y · Cited by 12
Shamsnajafabadi, H., Kaukonen, M. K., Bellingrath, J.-S., MacLaren, R. E., & Cehajic‐Kapetanovic, J. (2024) · Genes · doi:10.3390/genes15050625 · Cited by 11
Muhtaseb, A. W., & Duan, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.04.003 · Cited by 11
Prediction of Base Editing Efficiencies and Outcomes Using DeepABE and DeepCBE
Park, J., & Kim, H. K. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2879-9_3 · Cited by 11
Chen, C., Zheng, P., Chen, P., & Wu, D. (2023) · Biotechnology for Biofuels and Bioproducts · doi:10.1186/s13068-023-02443-8 · Cited by 10
Deconstructing cancer with precision genome editing
Johnson, G. A., Gould, S. I., & Rivera, F. J. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230984 · Cited by 11
Prime editing: A gene precision editing tool from inception to present
Liu, Z., Guo, D., Wang, D., Zhou, J., Chen, Q., & Lai, J. (2024) · The FASEB Journal · doi:10.1096/fj.202401692r · Cited by 13
SPLICER: a highly efficient base editing toolbox that enables in vivo therapeutic exon skipping
Miskalis, A., Shirguppe, S., Winter, J., Elias, G., Swami, D., Nambiar, A., Stilger, M., Woods, W. S., Gosstola, N. C., Gapinske, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54529-y · Cited by 13
Gene Editing in Ganoderma lucidum: Development, Challenges, and Future Prospects
He, S., Liu, Y., Zhang, Z., Cai, M., Hao, Y., & Hu, H. (2025) · Journal of Fungi · doi:10.3390/jof11040310 · Cited by 11
Predicting adenine base editing efficiencies in different cellular contexts by deep learning
Kissling, L., Mollaysa, A., Janjuha, S., Mathis, N., Marquart, K. F., Weber, Y., Moon, W. J., Lin, P. J. C., Fan, S. H. Y., Muramatsu, H., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03586-7 · Cited by 12
Precision multiplexed base editing in human cells using Cas12a-derived base editors
Schweitzer, A. Y., Adams, E. W., Nguyen, M. T. A., Lek, M., & Isaacs, F. J. (2025) · Nature Communications · doi:10.1038/s41467-025-59653-x · Cited by 10
A Molecular Glue Approach to Control the Half-Life of CRISPR-Based Technologies
Sreekanth, V., Jan, M., Zhao, K. T., Lim, D., Siriwongsup, S., Davis, J. R., McConkey, M. E., Kovalcik, V., Barkal, S., Law, B. K., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06230 · Cited by 12
Self-citationADARs: pleiotropy in function, versatility in application
Zhang, Y., Bryant, J., Herron, L., & Mali, P. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf672 · Cited by 9
Gustafsson, O., Krishna, S., Borate, S., Ghaeidamini, M., Liang, X., Saher, O., Cuellar, R., Birdsong, B. K., Roudi, S., Estupiñan, H. Y., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114038 · Cited by 11
Metadata
- Authors
- Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., Doudna, J. A., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2020-03-16
- Volume
- 38
- Issue
- 7
- Pages
- 883-891
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7357821
- OpenAlex
- W3012327875
- Cited by
- 1,020
- References
- 60
- Citations by year
- 2026: 158 · 2025: 196 · 2024: 192 · 2023: 192 · 2022: 148 · 2021: 103 · 2020: 29
- FWCI
- 38.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-20)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL053749)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- adenine base editing, ABE8e, phage-assisted continuous evolution, Cas12, processivity, off-target editing, fetal hemoglobin, PAM site
- MeSH terms
- Gene Editing, Adenine, Adenosine Deaminase, Bacteriophages, DNA, Humans, Mutation, RNA, Mutagenesis, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
